TheProfitWatch

BOLD - Boundless Bio, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.28 0.05 (3.91%) --- 0.0 (0.0%) -0.02 (-1.48%) 0.0 (0.0%) 0.01 (1.14%) -0.02 (-1.48%) -0.02 (-1.48%)

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.7
Diluted EPS:
-0.7
Basic P/E:
-1.9
Diluted P/E:
-1.9
RSI(14) 1m:
0.0
VWAP:
1.33
RVol:

Events

Period Kind Movement Occurred At

Related News